Search research articles
Contact Us
Filters
Showing results (121-130 of 197) with videos related to
Page
of 20
Sort By:
Archives of Internal Medicine
|
January 14, 2004
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses
Charles H Hennekens, Frank M Sacks, Andrew Tonkin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 17, 2009
NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry
D Craig Allred, Robert W Carlson, Donald A Berry, et al.
JAMA
|
January 28, 2010
Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial
David J Wilber, Carlo Pappone, Petr Neuzil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2005
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer
Roman Rouzier, Lajos Pusztai, Suzette Delaloge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials
Donald A Berry, Naoto T Ueno, Marcella M Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2017
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
Brian M Alexander, Sujuan Ba, Mitchel S Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2014
Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance)
Lawrence N Shulman, Donald A Berry, Constance T Cirrincione, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 5, 2005
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients
Lynn G Dressler, Donald A Berry, Gloria Broadwater, et al.
JAMA
|
May 22, 2012
Benefits and harms of CT screening for lung cancer: a systematic review
Peter B Bach, Joshua N Mirkin, Thomas K Oliver, et al.
The New England Journal of Medicine
|
October 12, 2007
HER2 and response to paclitaxel in node-positive breast cancer
Daniel F Hayes, Ann D Thor, Lynn G Dressler, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 197) with videos related to
Sort By:
Page
of 20
Archives of Internal Medicine
|
January 14, 2004
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses
Charles H Hennekens, Frank M Sacks, Andrew Tonkin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 17, 2009
NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry
D Craig Allred, Robert W Carlson, Donald A Berry, et al.
JAMA
|
January 28, 2010
Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial
David J Wilber, Carlo Pappone, Petr Neuzil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2005
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer
Roman Rouzier, Lajos Pusztai, Suzette Delaloge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials
Donald A Berry, Naoto T Ueno, Marcella M Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2017
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
Brian M Alexander, Sujuan Ba, Mitchel S Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2014
Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance)
Lawrence N Shulman, Donald A Berry, Constance T Cirrincione, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 5, 2005
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients
Lynn G Dressler, Donald A Berry, Gloria Broadwater, et al.
JAMA
|
May 22, 2012
Benefits and harms of CT screening for lung cancer: a systematic review
Peter B Bach, Joshua N Mirkin, Thomas K Oliver, et al.
The New England Journal of Medicine
|
October 12, 2007
HER2 and response to paclitaxel in node-positive breast cancer
Daniel F Hayes, Ann D Thor, Lynn G Dressler, et al.
Page
of 20